Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO Private Facebook Group
to join : go to
or contact
Ubiome Gut EXPLORER : 10% OFF
Join/Watch the weekly
TMAU UP Podcasts

Videos : TMAU stories

Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect

£ 943.03/GBP
$ 568.00/USD

TOTAL at today's ROE
£0.80/GBP = $1.00/USD

£1,398.07 = $1,745.14



Your currency will be automatically converted to USD or GBP by PayPal.

Option: pay with your credit card instead of PayPal account by clicking on either Donate button above.

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

Friday, September 28, 2012

Introducing Jimmy Lin, PhD, MD, Founder of Rare Genomics Institute

Dr. Jimmy Lin,MD, PhD, Founder of Rare Genomics Institute.

MEBO Research is proud to have Dr. Jimmy Lin as a member of the MEBO Research Institutional Review Board (IRB). One of Hacking Work's 100 Disruptive Heroes: Jimmy Lin is Founder of Rare Genomics Institute (RGI), empowering communities and accelerating research. RGI is a non-profit biotech venture that micro funds and enables genome sequencing for children with rare diseases. The Mission of RareGenomics is dedication to overcoming barriers, a culture of caring, focused on the individual, organizational transparency, and tangible results.

As noted in the RGI website,

To Our Patients

We will provide superior patient care, and do our best in everything to support our patients. We are patient-champions, fighting for the causes for those who have long been neglected by society.

To Our Donors

We promise to use all donated funds for the sole purpose of supporting our patients. We will be transparent in organizational processes so as to be worthy of the trust we gain from our donors.

Jimmy is the lead computational biologist for the ground-breaking cancer genome sequencing efforts from the Vogelstein Lab at Johns Hopkins. Their sequencing of the first 100+ cancer exomes in 5 different tissue types has helped lay the foundation for a revolution in cancer genomics.

We are most grateful for Jimmy's membership and participation in the MEBO IRB, and look forward to a long and fruitful relationship with him and his organization.


María de la Torre
Founder and Executive Director

A Public Charity
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)

SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.

Please use your credit card to make your donation to MEBO.

Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner

A EURORDIS and NORD Member Organization


Post a Comment